Fusheng Wu

1.2k total citations
24 papers, 883 citations indexed

About

Fusheng Wu is a scholar working on Cancer Research, Surgery and Molecular Biology. According to data from OpenAlex, Fusheng Wu has authored 24 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Fusheng Wu's work include Cancer-related molecular mechanisms research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and MicroRNA in disease regulation (5 papers). Fusheng Wu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and MicroRNA in disease regulation (5 papers). Fusheng Wu collaborates with scholars based in China and United States. Fusheng Wu's co-authors include Zeran Yang, Guohong Li, Lingjiao Wu, Qiangfeng Wang, Xiuming Zhu, Jie Xu, Rong Yang, Rong Jin, Anil Nanda and Shiyong Yu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and World Journal of Gastroenterology.

In The Last Decade

Fusheng Wu

23 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fusheng Wu China 14 435 379 128 104 90 24 883
Qijun Zheng China 13 266 0.6× 115 0.3× 87 0.7× 131 1.3× 95 1.1× 24 710
Katalin Éder Hungary 14 329 0.8× 165 0.4× 120 0.9× 189 1.8× 83 0.9× 19 905
Yoshito Nakamura Japan 14 447 1.0× 218 0.6× 81 0.6× 37 0.4× 131 1.5× 24 723
C Hanusch Germany 13 181 0.4× 138 0.4× 143 1.1× 82 0.8× 28 0.3× 29 612
Gour‐Shenq Kao Taiwan 11 434 1.0× 196 0.5× 163 1.3× 36 0.3× 55 0.6× 15 847
Laicheng Wang China 19 323 0.7× 87 0.2× 139 1.1× 263 2.5× 55 0.6× 53 1.1k
Angela Djanani Austria 15 298 0.7× 86 0.2× 131 1.0× 168 1.6× 65 0.7× 34 797
Qiang Xie China 15 332 0.8× 217 0.6× 116 0.9× 157 1.5× 103 1.1× 43 755
Hideki Mochizuki Japan 16 133 0.3× 132 0.3× 139 1.1× 72 0.7× 74 0.8× 53 904

Countries citing papers authored by Fusheng Wu

Since Specialization
Citations

This map shows the geographic impact of Fusheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fusheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fusheng Wu more than expected).

Fields of papers citing papers by Fusheng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fusheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fusheng Wu. The network helps show where Fusheng Wu may publish in the future.

Co-authorship network of co-authors of Fusheng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fusheng Wu. A scholar is included among the top collaborators of Fusheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fusheng Wu. Fusheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Ting, Chenyu Mao, Xiongfei Yu, et al.. (2020). <p>The Ectopic Expression of SurvivinT34A and FilC Can Enhance the Oncolytic Effects of Vaccinia Virus in Murine Gastric Cancer</p>. OncoTargets and Therapy. Volume 13. 1011–1025. 6 indexed citations
2.
Wang, Shao-Cheng, Yanyan Chen, Xiongfei Yu, et al.. (2018). miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer. Pathology - Research and Practice. 215(4). 676–682. 43 indexed citations
3.
Ren, Hongyu, Xianlin Zhao, Juan Li, et al.. (2017). Pharmacokinetics and pharmacodynamics of Da-Cheng-Qi decoction in the liver of rats with severe acute pancreatitis. World Journal of Gastroenterology. 23(8). 1367–1367. 27 indexed citations
5.
Cheng, Xiao, Fusheng Wu, Han Jiang, et al.. (2015). Hepatoid adenocarcinoma of the stomach: Nine case reports and treatment outcomes. Oncology Letters. 10(3). 1605–1609. 31 indexed citations
6.
Lan, Ying, et al.. (2015). Auricular acupuncture with seed or pellet attachments for primary insomnia: a systematic review and meta-analysis. BMC Complementary and Alternative Medicine. 15(1). 103–103. 73 indexed citations
7.
Wu, Lingjiao, Qiangfeng Wang, Jian Yao, et al.. (2014). MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large. Oncology Letters. 9(1). 213–218. 30 indexed citations
8.
Xie, Lianghai, Han Jiang, & Fusheng Wu. (2014). [Role of Wnt/β-catenin signaling pathway in promoting tumorigenesis of hepatocellular carcinoma].. PubMed. 34(6). 913–7. 1 indexed citations
10.
Yang, Zeran, Lingjiao Wu, Xiuming Zhu, et al.. (2013). MiR-29a modulates the angiogenic properties of human endothelial cells. Biochemical and Biophysical Research Communications. 434(1). 143–149. 47 indexed citations
11.
Yang, Rong, Xiongfei Yu, Liang Ma, & Fusheng Wu. (2012). Emergency management of a patient with severe airway obstruction resulting from poorly differentiated thyroid carcinoma: A case report. Oncology Letters. 4(4). 771–774. 5 indexed citations
12.
Xu, Jie, Xiuming Zhu, Lingjiao Wu, et al.. (2012). MicroRNA‐122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β‐catenin pathway. Liver International. 32(5). 752–760. 180 indexed citations
13.
Wu, Fusheng, Zeran Yang, & Guohong Li. (2009). Role of specific microRNAs for endothelial function and angiogenesis. Biochemical and Biophysical Research Communications. 386(4). 549–553. 135 indexed citations
14.
Li, Guohong, Rong Jin, Russell A. Norris, et al.. (2009). Periostin mediates vascular smooth muscle cell migration through the integrins ανβ3 and ανβ5 and focal adhesion kinase (FAK) pathway. Atherosclerosis. 208(2). 358–365. 129 indexed citations
15.
Wu, Fusheng, et al.. (2007). Calcitriol inhibits the growth of MHCC97 heptocellular cell lines by down‐modulating c‐met and ERK expressions. Liver International. 27(5). 700–707. 21 indexed citations
16.
Wu, Fusheng, et al.. (2006). Influence of age and sex on pharmacodynamics of propofol in neurosurgical patients: model development1. Acta Pharmacologica Sinica. 27(5). 629–634. 1 indexed citations
17.
Wu, Fusheng, Shusen Zheng, Lingjiao Wu, et al.. (2006). [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].. PubMed. 44(9). 603–8. 13 indexed citations
18.
Wu, Fusheng, et al.. (2005). [Prognostic factors influencing postoperative survival in patients with PubMed. 43(9). 579–83. 1 indexed citations
19.
Wu, Fusheng, Wenhe Zhao, Tingbo Liang, et al.. (2005). Survival factors after resection of small hepatocellular carcinoma.. PubMed. 4(3). 379–84. 16 indexed citations
20.
Wu, Fusheng, et al.. (2004). Malignant gastric carcinoids with liver metastasis.. PubMed. 3(3). 406–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026